Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
166M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
30M
-
Shares change
-
+2.42M
-
Total reported value, excl. options
-
$634M
-
Value change
-
+$55.5M
-
Number of buys
-
74
-
Number of sells
-
-36
-
Price
-
$21.11
Significant Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q4 2017
130 filings reported holding CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share as of Q4 2017.
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30M shares
of 166M outstanding shares and own 18.14% of the company stock.
Largest 10 shareholders include FMR LLC (5.76M shares), TRV GP, LLC (3.32M shares), BlackRock Inc. (2.65M shares), PERCEPTIVE ADVISORS LLC (2.49M shares), Vanguard Group Inc (1.2M shares), BVF INC/IL (1.12M shares), STATE STREET CORP (1.09M shares), MILLENNIUM MANAGEMENT LLC (837K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (753K shares), and Numeric Investors LLC (729K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.